Effects of Abnormal Iron Metabolism on EPO-STAT5 Signaling Pathway in Anemia Patients.
10.7534/j.issn.1009-2137.2018.06.024
- Author:
Yao ZHANG
1
;
Shuang HAN
1
;
Cha GUO
1
;
Qing-Xia ZHANG
1
;
Chun-Kang CHANG
2
Author Information
1. Department of Hematology, East Hospital of The Sixth People＇s Hospital, Shanghai Jiaotong University, Shanghai 201306, China.
2. Department of Hematology, East Hospital of The Sixth People＇s Hospital, Shanghai Jiaotong University, Shanghai 201306, China.E-mail:changchunkang7010@aliyun.com.
- Publication Type:Journal Article
- MeSH:
Anemia;
Anemia, Iron-Deficiency;
Erythropoietin;
Humans;
Iron;
STAT5 Transcription Factor;
Signal Transduction
- From:
Journal of Experimental Hematology
2018;26(6):1726-1730
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To study the effects of iron metabolism abnormality on EPO-STAT5 signaling pathway in anemia patients.
METHODS:According to diseases, the patients were divided into 3 groups: lower risk myelodysplastic syndrome (MDS) group (30 cases) including 14 cases of non-iron over load and 16 cases of iron over load, 12 cases of them were treated by iron chelation therapy; anemia of chronic disease (ACD) group (12 cases) and iron deficiency anemia (IDA) group (12 cases). In addition, the healthy control group was selected. The iron metaloslism index (SF, SI, TIBC), serum level of EPO, plasma level of P-STAT5 and STAT-5 mRNA expression in peripheral blood cells were detected and compared in different groups. Moreover, the effects of iron metabolism abnormality on the expression of EPO and STAT5 in anemia patients were analyzed.
RESULTS:compared with non-iron over load group, the EPO level in iron over load group significantly increased (P<0.05), the expression of STAT5 mRNA and P-STAT5 significantly decreased (P<0.05). After iron chelation therapy, the EPO level in serum significantly decreased (P<0.05), the expression of STAT5 mRNA and P-STAT5 was up-regulated significantly (P<0.05). Compared with healthy control group, the expression of EPO in ACD group was down-regulated significantly, while the expression of STAT5 mRNA was not different, but the P-STAT5 expression was down-regulated significantly (P<0.05). Compared with the healtly control group, the EPO expression in IDA group was enhanced significantly (P<0.05), the expression of STAT5 mRNA and P-STAT5 were also significantly enhanced (P<0.05).
CONCLUSION:The excessive iron load or chronic inflammation may inhibit the activation of EPO-STAT5 signaling pathway and aggravate the anemia.
